| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |